Back to search

Article

Proteome-wide serology reveals immune-defined subtypes of gastrointestinal disease in systemic sclerosis

2026-05-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Gastrointestinal (GI) involvement in systemic sclerosis (SSc) affects up to 90% of patients and is a major driver of morbidity and mortality. Despite its clinical importance, GI disease in SSc is highly heterogeneous, with upper and lower GI manifestations representing distinct phenotypic extremes whose underlying immunologic basis remains poorly defined. <h4>Methods</h4> W...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5fe63817-47c3-5e5b-9173-e4591840d72f
DOI
10.64898/2026.05.19.724137
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proteome-wide serology reveals immune-defined subtypes of gastrointestinal disease in systemic sclerosisDOI 10.64898/2026.05.19.724137
Novel autoantibodies in patients with systemic sclerosis and gastrointestinal dysfunction provide insight into disease pathogenesisSemantic proximity
Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry.Semantic proximity
Anti-Gephyrin antibodies: A novel specificity in patients with systemic sclerosis and lower bowel dysfunctionSemantic proximity
The Evolving Landscape of Systemic Sclerosis Pathogenesis: From Foundational Mechanisms to Organ-Specific ModifiersSemantic proximity
Emerging Blood Biomarkers in Systemic Sclerosis: From Single Molecules to Biomarker-Based Patient StratificationSemantic proximity
Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis.Semantic proximity
Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary HypertensionSemantic proximity
Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways.Semantic proximity
Oesophageal dysmotility patterns are associated with distinct clinical phenotypes and prognosis in patients with systemic sclerosis.Semantic proximity
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.Semantic proximity
Cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosisSemantic proximity
Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis.Semantic proximity
Select a neighboring publication to make it the new centre.